The U.S. Food and Drug Administration announced on April 10 that it’s changing the labels of birth control pills containing the compound drospirenone, adding information to warn users that numerous studies found as high as a three-fold increase in the risk of blood clots from those pills compared to other contraceptives on the market.
“Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills,” ...
continue reading...